P095: Personalised Modelling of Quality-Adjusted Survival Benefit and Cost-Effectiveness of using Proton Beam Therapy inthe Treatment of Intermediate-Stage Hodgkin Lymphoma in England

• David Jones,
• Rebecca Shakir,
• Paolo Candio,
• Johanna Ramroth,
• Jane Wolstenholme,
• Alastair Gray,
• David Cutter,
• Georgios Ntentas

Affiliations

David Jones

1 University of Oxford

Rebecca Shakir

1 University of Oxford

Paolo Candio

2 University of Birmingham

Johanna Ramroth

1 University of Oxford

Jane Wolstenholme

1 University of Oxford

Alastair Gray

1 University of Oxford

David Cutter

1 University of Oxford

Georgios Ntentas

1 University of Oxford